Porcine reproductive and respiratory syndrome (PRRS), a serious disease of swine caused by the PRRS virus (PRRSV), had a severe economic impact worldwide. As commonly used PRRS vaccines, the attenuated or inactivated vaccines, provide unsatisfactory immune protection, a new PRRS vaccine is urgently needed. In this study, a part of the PRRSV <i>ORF6</i> gene (from 253 to 519 bp) encoding the hydrophilic domain of PRRSV M protein was integrated into two <i>Listeria</i> strains via homologous recombination to generate two PRRS vaccine candidates, namely LI-M’ and LM-Δ<i>actAplcB</i>-M’. Both candidate vaccines showed similar growth rate as their parent strains in culture media, but presented different bacterial loads in target organs. As the integrated heterogenous gene was not expressed, LM-Δ<i>actAplcB</i>-M’ was excluded from the immunological test. In a mouse model, LI-M’ provoked both CD4+ and CD8+ T cell-mediated immunity. In addition, LI-M’ boosting dramatically enhanced CD8+ T cell-mediated immunity without affecting the response intensity of CD4+ T cell-mediated immunity. All of these data suggest that LI-M’ is a promising PRRS vaccine candidate.
Influence of the amino acid residues at 70 in M protein of porcine reproductive and respiratory syndrome virus on viral neutralization susceptibility to the serum antibody
